Source: MarketScreener

Pieris: Shareholder Alert: Ademi LLP investigates whether Pieris Pharmaceuticals, Inc. has obtained a Fair Price for its Public Shareholders

(marketscreener.com) MILWAUKEE, July 24, 2024 /PRNewswire/ -- Ademi LLP is investigating Pieris for possible breaches of fiduciary duty and other violations of law in its transaction with Palvella. Click here to learn how to join our...https://www.marketscreener.com/quote/stock/PIERIS-PHARMACEUTICALS-IN-22619465/news/Shareholder-Alert-Ademi-LLP-investigates-whether-Pieris-Pharmaceuticals-Inc-has-obtained-a-Fair-P-47460089/?utm_medium=RSS&utm_content=20240724

Read full article »
Annual Revenue
$25-100M
Employees
1-25
Stephen S. Yoder's photo - President & CEO of Pieris

President & CEO

Stephen S. Yoder

CEO Approval Rating

90/100

Read more